The authors of this study also showed that breast CSCs with a mesenchymal-like (CD44+/CD24–) phenotype reside at the invasive edge of the tumor, whereas a population of hybrid epithelial-mesenchymal (E/M) CSCs are localized within the tumor interior. Here, CD44 is linked to neoplasm.